Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HERC3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | FAM69A | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | NELFE | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | SIX4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | C6orf222 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | HAT1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | YY2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | TXLNB | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | IDI2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | SLC25A35 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |